Deborah M. Finucane

Bax-induced Caspase Activation and Apoptosis via Cytochromec Release from Mitochondria Is Inhibitable by Bcl-xL

Deborah M. Finucane, Ella Bossy‐Wetzel, Nigel J. Waterhouse et al. · Journal of Biological Chemistry · 1999 · 724 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Phosphatidylserine Externalization during CD95-induced Apoptosis of Cells and Cytoplasts Requires ICE/CED-3 Protease Activity

Séamus J. Martin, Deborah M. Finucane, Gustavo P. Amarante‐Mendes et al. · Journal of Biological Chemistry · 1996 · 382 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma

Myron S. Czuczman, Aron D. Thall, Thomas E. Witzig et al. · Journal of Clinical Oncology · 2005 · 148 citations · Full text

Pharmacy, Hematology, Pharmacokinetics +17

Collapse of the Inner Mitochondrial Transmembrane Potential Is Not Required for Apoptosis of HL60 Cells

Deborah M. Finucane, Nigel J. Waterhouse, Gustavo P. Amarante‐Mendes et al. · Experimental Cell Research · 1999 · 124 citations

Life Sciences, Cell Biology, Molecular Biology +14

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma

John P. Leonard, Jonathan W. Friedberg, Anas Younes et al. · Annals of Oncology · 2007 · 115 citations · Full text

Life Sciences, Hematology, Immunology +13